On this page
Give yourself a plan for the practical details
Starting treatment can involve more than remembering a dose. There may be a delivery to receive, a device to learn, a follow-up to arrange, and questions you only remember after the appointment ends.
This planner helps organize those details. It is not a prescription, a dosing calendar, or a promise that you will reach a particular weight by day 90. Your clinician sets the treatment and follow-up schedule; move the planning steps below to fit that schedule.
The medicine and presentation matter. The labels cited here describe FDA-approved Wegovy and Zepbound. They do not establish the safety or effectiveness of a compounded preparation. For that distinction, see compounded versus brand-name GLP-1 medications.
Before treatment: make the appointment count
Bring a current medication list, including supplements, and write down the health questions you most want answered. Include what you hope will become easier in daily life, such as planning meals or participating in an activity you enjoy. These goals give you something useful to revisit beyond a number on a scale.
Discuss pregnancy plans, breastfeeding, previous medication reactions, and your personal and family medical history. Wegovy and Zepbound have contraindications involving medullary thyroid cancer and MEN 2, and product-specific warnings and interactions require review. Tell the clinician about planned procedures involving anesthesia or deep sedation. 1 2
If you use oral hormonal contraception and are prescribed tirzepatide, discuss protection before starting. Zepbound's label advises a non-oral method or an added barrier method for four weeks after starting and four weeks after each dose increase. 2
Use the appointment to establish these six details:
- The exact medication, form, and written prescription instructions.
- How you will be shown to use the product you receive.
- Whom to ask about symptoms and how quickly that service responds.
- Which symptoms need urgent help instead of a routine message.
- What information your clinician wants at follow-up.
- When to request refills and how treatment will be reassessed.
Before the first dose: a ready-to-start checklist
Choose one place to keep the prescription instructions, pharmacy contact, appointment details, and care-team number. A phone note or folder is enough.
Check that you can answer each question below. If you cannot, ask before using the medication.
| Practical question | Your next step |
|---|---|
| Does the label match the prescription I expected? | Confirm any difference with the pharmacy. |
| Have I been trained on this exact device or vial? | Request a demonstration and repeat the instructions back. |
| Do I have all the necessary supplies? | Check with the dispensing pharmacy, including sharps disposal. |
| Do I understand storage and disposal dates? | Save the product-specific instructions where you keep the medicine. |
| What if I miss a dose or am unsure I received it? | Obtain instructions for this prescription rather than guessing. |
| Who can help after hours? | Save the agreed contact and emergency plan. |
If a compounded injectable prescription uses a vial and syringe, have the pharmacist show exactly how the written dose corresponds to your syringe. FDA has documented serious dosing errors with compounded semaglutide, including confusion about measurement and concentration. Do not use an online conversion chart in place of that explanation. 3
Your first 90 days, organized around check-ins
These are suggested planning windows, not required medical appointment intervals. Contact your care team sooner when needed.
| Planning window | Focus | Questions to bring to your care team |
|---|---|---|
| Before the first dose | Instructions, training, supplies, and contact details | “Can I explain back how I will use this? What should make me call?” |
| First week | Notice how the routine fits your day | “What symptoms have I had? Am I able to eat and drink?” |
| Weeks 2–4 | Review questions before the next prescribed step | “Do I need a check-in before a change? Is any symptom affecting daily life?” |
| Weeks 5–8 | Make food, movement, and refills manageable | “What is working? Where do I need more support?” |
| Weeks 9–12 | Review the whole treatment plan | “What benefits and problems are we seeing? What should the next phase look like?” |
| Around day 90 | Confirm the next practical plan | “When is my next review? What are my refill, cost, and follow-up arrangements?” |
Set reminders for the appointments and refill requests you actually agree on. Do not treat a calendar reminder as permission to change the dose.
Keep a small, useful record
A short note is often easier to maintain than a detailed daily diary. If your clinician asks for specific measurements, use their instructions. Otherwise, choose a format you can bring to an appointment without having to reconstruct the whole month.
Try these prompts:
- Routine: Was I able to follow the prescribed instructions? What was unclear?
- Eating and drinking: What felt manageable, and what was difficult?
- Symptoms: What happened, when did it start, and did it interrupt sleep, work, or meals?
- Daily life: What feels easier or harder than before treatment?
- Next question: What do I need answered before the next refill or appointment?
Avoid changing several parts of your routine at once simply to meet someone else's online plan. Bring practical barriers into the conversation: a shift schedule, caregiving, a limited grocery budget, or a dislike of certain foods all matter when building a routine you can follow.
Our food guide and small-appetite meal ideas can help you prepare questions about meals. If you are starting semaglutide injections, our first-week guide focuses on the immediate practical details.
Know what should interrupt the plan
Do not wait for a scheduled check-in when symptoms are severe. Stop treatment and seek urgent medical advice for severe, persistent abdominal pain. Breathing trouble or swelling of the face or throat needs emergency help. Persistent vomiting or diarrhea, inability to keep fluids down, or reduced urination needs prompt assessment. These concerns appear in semaglutide and tirzepatide safety information. 1 2
Read the full side-effect guide and your own medication information. The examples above are not a complete list of possible problems.
Use day 90 to plan forward
Bring your notes and ask your clinician to review benefits, symptoms, nutrition, activity, and any monitoring they recommend. Ask what would lead them to continue, adjust, or change treatment. A refill should be part of an understood plan rather than an automatic assumption.
Include the financial side. Check the next charge and any change in coverage or pricing. Our cost guide can help you compare the next few months without treating the first 90 days as the end of care.
Common questions
Should I increase the dose on a set date?
Follow your own prescription and clinician's instructions. Do not accelerate a schedule because someone else reports faster progress, or assume a planning milestone in this article is a dosing instruction. 1 2
What if medication arrives warm or the packaging seems wrong?
Do not use it while you are resolving the problem. Contact the dispensing pharmacy. FDA advises against using injectable GLP-1 shipments that arrive warm or inadequately refrigerated. 4
Should I wait until day 90 to report a problem?
No. The planner is for organization. Use your care team's contact instructions whenever a concern arises, and seek urgent or emergency care when symptoms require it.
Read next, in order
Go deeper on the questions in this guide.
- 01
Your First Week on Semaglutide Injections
A practical first-week checklist for semaglutide injections: confirm instructions, organize supplies, track symptoms, and know when to call for help.
- 02
GLP-1 Side Effects: What to Watch For and When to Get Help
A practical guide to digestive symptoms on semaglutide or tirzepatide, what to tell your clinician, and warning signs that need urgent care.
- 03
Your First Week on Tirzepatide: What to Expect
A practical first-week checklist for tirzepatide: confirm your exact device, store it correctly, track symptoms, and know which signs need urgent care.
- 04
Nausea on a GLP-1: Questions and Practical Support
Practical support for nausea on semaglutide or tirzepatide, plus the warning signs that need urgent care instead of home remedies.
- 05
Preparing for Your GLP-1 Follow-Up Appointment
A practical agenda for your next semaglutide or tirzepatide follow-up: what to bring, what your clinician checks, and which symptoms cannot wait for the visit.
- 06
Constipation on a GLP-1: What to Discuss With Your Clinician
Practical steps for constipation on semaglutide or tirzepatide, and the warning signs — like constant abdominal pain or an inability to pass gas — that need prompt medical care.
- 07
Traveling With GLP-1 Medication: A Preparation Checklist
What the labels and TSA say about carrying GLP-1 pens through security and keeping them in range, plus a dated checklist of questions to settle with your prescriber and pharmacy before you leave.
- 08
Feeling Tired on a GLP-1: What to Bring Up at Follow-Up
Warning signs that need prompt care, the possible contributors to tiredness on semaglutide or tirzepatide, and a log to bring to your follow-up so your clinician can look at the whole picture.
- 09
Nervous About GLP-1 Injections? Questions and Support Options
Needle nerves are common and workable. Here is what to ask for before your first injection, what the CDC suggests for needle fear, and when to ask for more support.
- 10
Why Weight Loss on a GLP-1 May Be Slower Than Expected
Why GLP-1 weight loss can look slow in the first months, what the Wegovy and Zepbound trials actually measured, and what to ask at a follow-up.
- 11
Acid Reflux During GLP-1 Treatment: Questions to Ask
What to do first if heartburn or reflux shows up on semaglutide or tirzepatide: the warning signs that need care now, what is and is not known, and questions for your clinician.
- 12
A Weight-Loss Plateau on a GLP-1: Questions for Your Clinician
What the Wegovy and Zepbound trial curves show about weight leveling off, what a stall can and cannot mean, and a log and question list for your clinician.
- 13
Diarrhea During GLP-1 Treatment: What to Know
What to do about diarrhea on semaglutide or tirzepatide: the signs of dehydration and other warning signs that need prompt care, how to stay hydrated, and what to tell your clinician.
- 14
How to Find the Right Storage Instructions for Your GLP-1
Where storage instructions for your GLP-1 actually live, why the same brand has different rules by presentation, and who to ask when yours is compounded.
- 15
Hair Shedding During Weight Loss: What to Ask
When hair shedding during weight loss deserves a clinician's attention, what the Wegovy and Zepbound labels report, why timing matters, and a log and questions to bring to your appointment.
- 16
How Long Might GLP-1 Treatment Continue?
No universal timeline exists for GLP-1 weight treatment. See what trials show after stopping, what a clinician reviews, and questions to ask about duration.
- 17
Stomach Pain on a GLP-1: When to Get Medical Help
Which kinds of stomach pain on semaglutide or tirzepatide call for urgent care, which warrant a same-day call, and what to tell your clinician about pain that is milder.
- 18
Headaches During GLP-1 Treatment: What to Track
Which headache warning signs need urgent care, what the semaglutide and tirzepatide labels say about headache, and a log to bring to your clinician.
- 19
Alcohol and GLP-1 Treatment: What to Discuss With Your Clinician
What the medicine pages we read say and do not say about alcohol and semaglutide or tirzepatide, which warning signs come first, and a standard-drink worksheet to bring to your clinician.
- 20
Stopping a GLP-1: What to Discuss Before Changing Treatment
What the labels and trials say about stopping semaglutide or tirzepatide, which situations call for contacting your clinician now, and a checklist for planning a pause or an end to treatment together.
- 21
GLP-1 Injection Site Reactions: When to Contact Your Care Team
What the prescribing information says about injection site reactions on Wegovy and Zepbound, which signs point to an allergic reaction, and what to log before you call.
References
- Wegovy Prescribing Information and Medication Guide — Novo Nordisk
- Zepbound Prescribing Information — Eli Lilly
- FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products — U.S. Food and Drug Administration
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. Food and Drug Administration
For your information. This article provides general education and does not replace medical advice or an individual evaluation. Talk to your clinician before starting, changing, or stopping treatment. Compounded medications are not FDA-approved.
